statement
Estimated savings are ₹3,541 crore, with 85 companies reporting revised MRPs for 121 drugs.
A statement by 85 companies. Statements are as reported by the cited publishers — not verified by DecisionGateway.
₹3,541 crore, with 85 companies reporting revised MRPs for 121 drugs
Discussion
Related claims
Estimated savings are ₹3,357.49 crore (as on November 4, 2026), with 70 companies reporting revised MRPs for 120 drugs.post author · statement85 companies have submitted information on revised MRP for 121 drugs.post author · statementAs of 4 November 2026, 70 companies had announced revised MRPs for 120 medicines.post · statementThere will be a saving of ₹3,541 crore.post author · predictionEstimated savings amount to ₹3,357.49 crore (as of 4 November 2026).post · statementCompanies have reported an average of 50% to 75% in MRP reductions, with the highest at 96.45%.Companies · statement